Ustekinumab in Crohn's disease: Real‐world outcomes from the Sicilian network for inflammatory bowel diseases

BACKGROUND AND AIM: Ustekinumab is approved in Europe for the treatment of moderate to severe Crohn's disease (CD). Italian real‐life data are scarce, so the aim of this study was to assess the effectiveness and safety of ustekinumab in an Italian cohort of CD patients. METHODS: Data of patient...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JGH Open
Main Authors: Viola, Anna, Muscianisi, Marco, Macaluso, Fabio S, Ventimiglia, Marco, Cappello, Maria, Privitera, Antonino C, Magnano, Antonio, Pluchino, Dario, Magrì, Giovanni, Ferracane, Concetta, Mocciaro, Filippo, Garufi, Serena, Giuffrida, Enrica, Costantino, Giuseppe, Fiocco, Gabriele, Grova, Mauro, Guida, Laura, Alibrandi, Angela, Orlando, Ambrogio, Fries, Walter
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Publishing Asia Pty Ltd 2021
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7936616/
https://ncbi.nlm.nih.gov/pubmed/33732883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgh3.12502
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados